Over the last 7 days, the Biotech industry has dropped 1.0%, driven by a pullback from MorphoSys of 11%. The industry has fallen 6.8% in the last year. As for the next few years, earnings are expected to grow by 65% per annum.
Has the German Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 03 Oct 2023 | €3.9b | €971.6m | -€197,588,171.00 | 9.7x | -19.6x | 4x |
Thu, 31 Aug 2023 | €4.0b | €954.5m | -€53,175,027.00 | 19.1x | -74.7x | 4.2x |
Sat, 29 Jul 2023 | €4.1b | €955.5m | -€219,213,323.00 | 29.2x | -18.7x | 4.3x |
Mon, 26 Jun 2023 | €4.0b | €967.4m | -€212,883,319.00 | 27.9x | -18.9x | 4.2x |
Wed, 24 May 2023 | €4.1b | €967.4m | -€209,726,026.00 | 35x | -19.6x | 4.3x |
Fri, 21 Apr 2023 | €3.6b | €927.5m | -€212,539,789.00 | 13.6x | -16.9x | 3.9x |
Sun, 19 Mar 2023 | €3.3b | €890.4m | -€224,291,844.00 | 9.9x | -14.9x | 3.8x |
Tue, 14 Feb 2023 | €3.0b | €612.2m | -€74,748,337.00 | 11x | -40.6x | 5x |
Thu, 12 Jan 2023 | €3.1b | €611.9m | -€53,407,435.00 | 11.6x | -57.6x | 5x |
Sat, 10 Dec 2022 | €3.1b | €611.9m | -€53,407,435.00 | 11.3x | -57.4x | 5x |
Mon, 07 Nov 2022 | €2.6b | €624.9m | -€39,165,157.00 | 8.1x | -65.2x | 4.1x |
Wed, 05 Oct 2022 | €2.6b | €627.4m | -€129,805,157.00 | 5.1x | -19.7x | 4.1x |
Fri, 02 Sep 2022 | €2.6b | €605.7m | -€150,021,513.00 | 5.7x | -17.5x | 4.3x |
Sun, 31 Jul 2022 | €3.5b | €772.0m | -€724,268,362.00 | n/a | -4.8x | 4.5x |
Tue, 28 Jun 2022 | €3.4b | €768.8m | -€724,082,241.00 | n/a | -4.7x | 4.4x |
Thu, 26 May 2022 | €3.3b | €768.8m | -€724,082,241.00 | n/a | -4.6x | 4.3x |
Sat, 23 Apr 2022 | €3.6b | €807.7m | -€693,827,813.00 | n/a | -5.2x | 4.5x |
Mon, 21 Mar 2022 | €3.6b | €806.5m | -€675,731,845.00 | n/a | -5.3x | 4.4x |
Wed, 16 Feb 2022 | €3.7b | €789.6m | -€311,283,353.00 | n/a | -11.8x | 4.7x |
Fri, 14 Jan 2022 | €3.9b | €789.6m | -€311,283,353.00 | n/a | -12.6x | 5x |
Sun, 12 Dec 2021 | €4.0b | €789.6m | -€311,690,565.00 | n/a | -12.8x | 5.1x |
Tue, 09 Nov 2021 | €4.4b | €771.2m | -€257,628,521.00 | n/a | -17.2x | 5.7x |
Thu, 07 Oct 2021 | €4.3b | €768.9m | -€232,876,055.00 | n/a | -18.5x | 5.6x |
Sat, 04 Sep 2021 | €4.4b | €769.4m | -€175,243,228.00 | 1.4x | -24.9x | 5.7x |
Mon, 02 Aug 2021 | €4.4b | €769.4m | -€175,243,228.00 | 1.3x | -24.9x | 5.7x |
Thu, 06 May 2021 | €5.3b | €749.9m | -€236,050,839.00 | 1.1x | -22.6x | 7.1x |
Sun, 07 Feb 2021 | €6.0b | €930.9m | -€76,599,954.23 | 33.1x | -79x | 6.5x |
Sat, 31 Oct 2020 | €5.0b | €857.2m | -€136,640,199.02 | 55.3x | -36.9x | 5.9x |
-43.4x
Which industries have driven the changes within the German Healthcare industry?
DE Market | -1.19% | |
Healthcare | -1.57% | |
Biotech | -1.92% | |
Biotech | -1.92% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
FYB Formycon | €57.30 | 4.4% +€38.5m | -20.6% | PS13.4x | |
T9G Vidac Pharma Holding | €0.45 | 21.6% +€4.1m | n/a | n/a | |
T5O bioXXmed | €1.48 | 5.7% +€411.0k | -20.4% | PS621.6x | |
ECX1 Epigenomics | €0.69 | 6.2% +€170.7k | -50.4% | PS6.6x |